CELLAAX COMPLETES PHASE 1 TRIAL FOR GENETIC BLINDNESS USING CELLULAR THERAPY
CELLAAX Malaysia, a biopharmaceutical company engaged in the research and development of cellular therapy, recently completed its Phase 1 clinical...
Cellular Therapy is at the core of what we do. We utilise the transplantation of live human cells to address various health conditions that require the replacement, repair or regeneration of damaged cells and tissues in the body.
We introduced CELLAAX Therapy as our innovative driving force in regenerative medicine.
Our three main focuses are:
CELLAAX Therapy uses the regenerative properties found in Mesenchymal Stem Cells (MSC) to stimulate the repair mechanism of the body to treat diseased, dysfunctional and damaged cells and tissues.
Our advanced protocols are backed and proven by science to treat a myriad of conditions.
*Each patient is attended to on a case-to-case basis. Treatment will vary for each patient
Get to know more about our NK treatment here
Our innovative Mesenchymal Stem Cells Secretome is formulated with natural ingredients used to trigger the body’s repair mechanism which helps to:
Discover more about our superEXO formula
Unlike MSCs and NKCs, Secretomes are a form of cell-free therapy that utilizes the bioproteins released from MSCs. MSCs and NKCs involve the use of living cells.
Although they function similarly in helping to regenerate and target inflammation, Secretomes work on improving the intercellular communication between cells and work best for treatments that benefit from cell-to-cell signalling.
Secretome Therapy is popular for its regenerative qualities similar to proven therapies such as platelet-rich plasma therapy.
Our team comprises of accomplished experts in cellular therapy. Our scientists and doctors are always on the quest to push the boundaries of Regenerative Medicine to bring new frontiers in treating serious illnesses.
December 20, 2021
Retinitis Pigmentosa is a form of inherited genetic eye condition that causes the gradual loss of vision and in most cases, leads to blindness.
September 13, 2021
Patients that suffer from a stroke are subjected to adverse effects, leaving them debilitated and paralyzed and in some instances, unable to communicate. With our MSC treatment, patients can expect to regain function in areas that have suffered.
We have a diverse team of research and development scientists and medical doctors ready to develop suitable treatment protocols from targeting a specific disease to overall improvement of health quality and life.
We follow international standards in safety and protocols, and our cord tissue-derived mesenchymal stem cells are of the best quality, sourced from Southeast Asia’s leading cGMP manufacturing laboratory.
Speak to our experts to find out more
CELLAAX Malaysia, a biopharmaceutical company engaged in the research and development of cellular therapy, recently completed its Phase 1 clinical...
I believe some of us have come across stem cells treatment in certain diseases. In orthopaedics, stem cells have been...
WhatsApp us